English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 29 June 2016, 15:00 HKT/SGT
Share:
    

Source: Neste Jacobs Oy
Neste Jacobs Playing a Major Role in Asia's Largest Biopharma Project

ESPOO, Finland, June 29, 2016 - (ACN Newswire) - Technology, engineering and project management company Neste Jacobs has worked on an assignment to prepare conceptual and basic design for Asia's largest human blood plasma fractionation plant project. These phases of the project are now successfully completed to enable the implementation of the project by Sichuan Yuanda Shuyang Pharmaceutical Company.

Neste Jacobs has accumulated vast experience in human plasma fractionation over the last 40 years and the company has in-depth understanding of plasma technologies, production processes, operational aspects and cost levels required for a fully functional human plasma fractionation plant. This highly regulated biopharmaceutical sector sets high standards for the design and operation of the facility. Product safety, regulatory compliance, traceability and robust operability must be built-in during all design steps starting from conceptual and basic design now completed by Neste Jacobs.

"This project demonstrates that we are the world's leading expert in this very demanding bioindustry field", says Neste Jacobs CEO, Jarmo Suominen. "We have thorough understanding of various blood plasma technologies and a comprehensive network of partnerships in this field taking us way beyond our competition."

The plant now goes to the implementation phase, being built in China. "During the conceptual and basic phases of this project we have greatly contributed to our customer quality and functionality of the plant. Our approach integrates technology, concepts and process knowledge within the automated operations and constructability. This way our customers can be confident about the functionality of the as such complex plasma fractionation plant", says Neste Jacobs Bioindustries Sales Director, Kari Kaskes. "We are without doubt a number one company in front line development of global bioindustries."

Read more about Neste Jacobs' Biopharma expertise at http://www.nestejacobs.com/industries/biopharma/

About Neste Jacobs

Neste Jacobs is a preferred solution provider of high-quality technology, engineering and project services for a wide range of industries in the fields of oil and gas, petrochemicals, chemicals, biorefining, biochemicals, biopharma and industrial infrastructure. We have 60 years of experience in technology development and industrial investment projects as well as maintenance and performance improvement in Europe, North and South America, Asia and the Middle East. In addition to our home market Nordic countries we are looking to grow in the global expanding markets. We employ 1300 professionals globally. www.nestejacobs.com

For more information, please contact:
Jarmo Suominen, CEO, Neste Jacobs Oy, tel. +358 50 458 3399
Kari Kaskes, Sales Director, Bioindustries, Neste Jacobs Oy, tel. +358 50 458 9603

Topic: Press release summary
Source: Neste Jacobs Oy

Sectors: Science & Research, BioTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2022 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Neste Jacobs Oy Releated News
June 29, 2016 15:00 HKT/SGT
Neste Jacobs在亞洲最大的生物製藥項目中扮演主要角色
June 29, 2016 15:00 HKT/SGT
Neste Jacobs在亚洲最大的生物制药项目中扮演主要角色
More news >>
Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575